Temporal genomic analysis of <i>Plasmodium falciparum</i> reveals increased prevalence of mutations associated with delayed clearance following treatment with artemisinin-lumefantrine in Choma District, Southern Province, Zambia
Abebe A. Fola(John Brown University), Jeffrey A. Bailey(John Brown University), Ben Katowa(Golden Valley Agricultural Research Trust), Douglas E. Norris(Johns Hopkins University), Amy Wesolowski(Johns Hopkins University), Philip E. Thuma(Golden Valley Agricultural Research Trust), William J. Moss(Johns Hopkins University), Harry Hamapumbu(Golden Valley Agricultural Research Trust), Jonathan J. Juliano(University of North Carolina at Chapel Hill), Tamaki Kobayashi(Johns Hopkins University), Michael Musonda(Golden Valley Agricultural Research Trust), Jennifer C. Stevenson(Golden Valley Agricultural Research Trust), Timothy Shields(Johns Hopkins University), Japhet Matoba(Golden Valley Agricultural Research Trust)
Cited by 7
Related Papers
Deployment of convalescent plasma for the prevention and treatment of COVID-19
|Journal of Clinical Investigation|2020|863
A Worldwide Map of<i>Plasmodium falciparum</i>K13-Propeller Polymorphisms
|New England Journal of Medicine|2016|574
Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia
|Nature Microbiology|2023|190
Drug-Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo Using High-Throughput Molecular Inversion Probes
|The Journal of Infectious Diseases|2018|147